TIMM17B
gene geneOn this page
Also known as DXS9822JM3
Summary
TIMM17B (translocase of inner mitochondrial membrane 17B, HGNC:17310) is a protein-coding gene on chromosome Xp11.23, encoding Mitochondrial import inner membrane translocase subunit Tim17-B (O60830). Essential component of the TIM23 complex, a complex that mediates the translocation of transit peptide-containing proteins across the mitochondrial inner membrane.
This gene encodes a multipass transmembrane protein that forms an integral component of the mitochondrial translocase TIM23 complex. This complex facilitates the transport of mitochondrial proteins from the cytosol across the mitochondrial inner membrane and into the mitochondrion. There is a pseudogene for this gene on chromosome 12. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 10245 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 41 total
- MANE Select transcript:
NM_001395498
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17310 |
| Approved symbol | TIMM17B |
| Name | translocase of inner mitochondrial membrane 17B |
| Location | Xp11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DXS9822, JM3 |
| Ensembl gene | ENSG00000126768 |
| Ensembl biotype | protein_coding |
| OMIM | 300249 |
| Entrez | 10245 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 11 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000376582, ENST00000396779, ENST00000464663, ENST00000465150, ENST00000466995, ENST00000472645, ENST00000490755, ENST00000495490, ENST00000696123, ENST00000696124, ENST00000876514, ENST00000920114, ENST00000920115, ENST00000920116
RefSeq mRNA: 4 — MANE Select: NM_001395498
NM_001167947, NM_001395497, NM_001395498, NM_005834
CCDS: CCDS14308, CCDS55411
Canonical transcript exons
ENST00000696123 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003637424 | 48895038 | 48895101 |
| ENSE00003706168 | 48894097 | 48894225 |
| ENSE00003707693 | 48893900 | 48894010 |
| ENSE00003710359 | 48896759 | 48896858 |
| ENSE00003966076 | 48897724 | 48897768 |
| ENSE00003966078 | 48893449 | 48893817 |
Expression profiles
Bgee: expression breadth ubiquitous, 251 present calls, max score 96.55.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 63.7279 / max 422.1903, expressed in 1824 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 199190 | 62.6542 | 1824 |
| 199191 | 0.7003 | 449 |
| 199189 | 0.3734 | 180 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 96.55 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 96.17 | gold quality |
| gastrocnemius | UBERON:0001388 | 95.48 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 94.96 | gold quality |
| muscle of leg | UBERON:0001383 | 94.82 | gold quality |
| heart left ventricle | UBERON:0002084 | 94.43 | gold quality |
| right atrium auricular region | UBERON:0006631 | 94.31 | gold quality |
| granulocyte | CL:0000094 | 94.16 | gold quality |
| cardiac ventricle | UBERON:0002082 | 94.12 | gold quality |
| adenohypophysis | UBERON:0002196 | 93.82 | gold quality |
| right adrenal gland | UBERON:0001233 | 93.59 | gold quality |
| body of stomach | UBERON:0001161 | 93.57 | gold quality |
| lower esophagus | UBERON:0013473 | 93.28 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 93.28 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 93.21 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 93.18 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 93.17 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.15 | gold quality |
| cardiac atrium | UBERON:0002081 | 93.14 | gold quality |
| popliteal artery | UBERON:0002250 | 93.14 | gold quality |
| prefrontal cortex | UBERON:0000451 | 93.13 | gold quality |
| tibial artery | UBERON:0007610 | 93.13 | gold quality |
| pituitary gland | UBERON:0000007 | 93.12 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 93.11 | gold quality |
| heart | UBERON:0000948 | 93.10 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 93.00 | gold quality |
| muscle organ | UBERON:0001630 | 92.98 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 92.98 | gold quality |
| metanephros cortex | UBERON:0010533 | 92.89 | gold quality |
| nucleus accumbens | UBERON:0001882 | 92.63 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 12.32 |
| E-MTAB-7606 | no | 306.02 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
18 targeting TIMM17B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-3151-5P | 99.86 | 63.83 | 1069 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-6797-5P | 99.61 | 66.55 | 2084 |
| HSA-MIR-125A-5P | 99.36 | 70.59 | 1640 |
| HSA-MIR-125B-5P | 99.36 | 70.36 | 1662 |
| HSA-MIR-4292 | 99.16 | 65.57 | 1767 |
| HSA-MIR-6791-5P | 99.16 | 65.92 | 1844 |
| HSA-MIR-7155-5P | 98.65 | 66.14 | 1290 |
| HSA-MIR-4664-5P | 98.17 | 65.07 | 1020 |
| HSA-MIR-10526-3P | 97.86 | 64.97 | 1342 |
| HSA-MIR-342-5P | 97.25 | 64.10 | 817 |
| HSA-MIR-7976 | 95.75 | 65.67 | 1186 |
| HSA-MIR-874-3P | 95.02 | 65.66 | 806 |
| HSA-MIR-6889-5P | 90.26 | 64.13 | 291 |
Literature-anchored findings (GeneRIF, showing 1)
- The findings of this study together provide the first evidence that EspZ localizes to host mitochondria and that TIM17b contributes to protection against rapid cell death during EPEC infection. (PMID:21947777)
Cross-species orthologs
11 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | timm17b | ENSDARG00000060124 |
| mus_musculus | Timm17b | ENSMUSG00000031158 |
| rattus_norvegicus | Timm17b | ENSRNOG00000063664 |
| drosophila_melanogaster | Tim17b2 | FBGN0020371 |
| drosophila_melanogaster | CG1724 | FBGN0031164 |
| drosophila_melanogaster | Tim17a2 | FBGN0037307 |
| drosophila_melanogaster | Tim17b1 | FBGN0037310 |
| drosophila_melanogaster | Tim17a1 | FBGN0038018 |
| drosophila_melanogaster | Tim17b | FBGN0263977 |
| caenorhabditis_elegans | WBGENE00017069 | |
| caenorhabditis_elegans | WBGENE00017119 |
Paralogs (1): TIMM17A (ENSG00000134375)
Protein
Protein identifiers
Mitochondrial import inner membrane translocase subunit Tim17-B — O60830 (reviewed: O60830)
All UniProt accessions (5): O60830, A0A8Q3SIA0, V9GYK7, V9GYS0, V9GYU0
UniProt curated annotations — full annotation on UniProt →
Function. Essential component of the TIM23 complex, a complex that mediates the translocation of transit peptide-containing proteins across the mitochondrial inner membrane.
Subunit / interactions. Component of the TIM23 complex at least composed of TIMM23, TIMM17 (TIMM17A or TIMM17B) and TIMM50. The complex interacts with the TIMM44 component of the PAM complex and with DNAJC15.
Subcellular location. Mitochondrion inner membrane.
Tissue specificity. Expression is abundant in heart and skeletal muscle, intermediate in brain, and weak in pancreas, placenta, kidney and liver.
Post-translational modifications. Forms one disulfide bond.
Similarity. Belongs to the Tim17/Tim22/Tim23 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O60830-1 | 1 | yes |
| O60830-2 | 2 |
RefSeq proteins (4): NP_001161419, NP_001382426, NP_001382427, NP_005825 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005678 | Tim17 | Family |
Pfam: PF02466
UniProt features (7 total): transmembrane region 3, chain 1, region of interest 1, disulfide bond 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O60830-F1 | 81.10 | 0.62 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 9–78
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-1268020 | Mitochondrial protein import |
| R-HSA-9609507 | Protein localization |
MSigDB gene sets: 145 (showing top):
GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, ENK_UV_RESPONSE_KERATINOCYTE_UP, GOBP_PROTEIN_TARGETING, RIZKI_TUMOR_INVASIVENESS_3D_DN, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, MODULE_66, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN, GOCC_MITOCHONDRIAL_ENVELOPE, MODULE_88, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_PROTEIN_TRANSMEMBRANE_TRANSPORT, WONG_MITOCHONDRIA_GENE_MODULE, GOBP_PROTEIN_LOCALIZATION_TO_MITOCHONDRION, GOBP_PROTEIN_TARGETING_TO_MITOCHONDRION, MODULE_11
GO Biological Process (4): obsolete protein targeting to mitochondrion (GO:0006626), intracellular protein transport (GO:0006886), protein import into mitochondrial matrix (GO:0030150), protein transport (GO:0015031)
GO Molecular Function (2): transmembrane protein transporter activity (GO:0008320), protein binding (GO:0005515)
GO Cellular Component (4): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), TIM23 mitochondrial import inner membrane translocase complex (GO:0005744), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Protein localization | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular protein localization | 2 |
| protein transport | 1 |
| intracellular transport | 1 |
| protein transmembrane import into intracellular organelle | 1 |
| protein localization to mitochondrion | 1 |
| import into the mitochondrion | 1 |
| mitochondrial protein import pathway | 1 |
| transport | 1 |
| establishment of protein localization | 1 |
| macromolecule transmembrane transporter activity | 1 |
| protein transmembrane transport | 1 |
| protein transporter activity | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| inner mitochondrial membrane protein complex | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1424 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TIMM17B | TIMM23 | O14925 | 984 |
| TIMM17B | TIMM50 | Q3ZCQ8 | 956 |
| TIMM17B | TOMM20 | Q15388 | 850 |
| TIMM17B | TOMM70 | O94826 | 800 |
| TIMM17B | DNAJC19 | Q96DA6 | 760 |
| TIMM17B | PAM16 | Q9Y3D7 | 709 |
| TIMM17B | OXA1L | Q15070 | 681 |
| TIMM17B | TIMM21 | Q9BVV7 | 665 |
| TIMM17B | TIMM44 | O43615 | 647 |
| TIMM17B | TIMM22 | Q9Y584 | 644 |
| TIMM17B | TIMM10B | Q9Y5J6 | 607 |
| TIMM17B | TIMM10 | P62072 | 591 |
| TIMM17B | TIMM9 | Q9Y5J7 | 571 |
| TIMM17B | ROMO1 | P60602 | 563 |
| TIMM17B | TIMM8B | Q9Y5J9 | 549 |
IntAct
106 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| IFT70B | IFT56 | psi-mi:“MI:0914”(association) | 0.790 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| TIMM17B | TIMM23 | psi-mi:“MI:0914”(association) | 0.670 |
| TIMM23 | TIMM17B | psi-mi:“MI:0915”(physical association) | 0.670 |
| MYG1 | TIMM17B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM17B | MYG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM17B | TEX44 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM17B | MPC2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM17B | CIDEB | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM17B | RHBDD2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CRYAA | TIMM17B | psi-mi:“MI:0915”(physical association) | 0.560 |
| DYNC1H1 | TIMM17B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM17B | ATN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM17B | psi-mi:“MI:0915”(physical association) | 0.560 | |
| TIMM17B | F13A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM17B | FGFR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRN | TIMM17B | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRIN2C | TIMM17B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM17B | GSN | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM17B | HSPB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PAK1 | TIMM17B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM17B | WFS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM17B | GIPC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM17B | KIF1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TIMM17B | RNF11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UBQLN1 | TIMM17B | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (56): TIMM23 (Affinity Capture-Western), TIMM50 (Affinity Capture-Western), DNAJC15 (Affinity Capture-Western), PAM16 (Affinity Capture-Western), TIMM17B (Affinity Capture-Western), TIMM17B (Affinity Capture-Western), CREB3 (Two-hybrid), TIMM17B (Affinity Capture-MS), TIMM17B (Affinity Capture-MS), TIMM17B (Affinity Capture-MS), TIMM17B (Affinity Capture-MS), TIMM17B (Affinity Capture-MS), TIMM17B (Affinity Capture-MS), TTC30B (Affinity Capture-MS), TIMM17B (Affinity Capture-MS)
ESM2 similar proteins: A2RVP7, A2VDV9, A4IFL0, O14925, O35093, O35094, O35857, O43615, O60830, P0CR88, P0CR89, P59670, Q02921, Q2HJE9, Q2KHV4, Q2UAP8, Q38820, Q3B8P0, Q3ZBE6, Q4V8S3, Q5BIN4, Q5M7K0, Q5R5H4, Q5RDD0, Q5REX0, Q5SRD1, Q5U4F4, Q5U4U5, Q5XH94, Q5XJY4, Q5ZLL0, Q6BZY4, Q6GQ39, Q6INU6, Q6NWD4, Q7T2P6, Q86UB9, Q9C1E8, Q9CQ85, Q9CYV5
Diamond homologs: O35092, O44477, O60830, P39515, P59670, P87130, Q2HJE9, Q2UAP8, Q54K35, Q5BIN4, Q6BZY4, Q6NKU9, Q94EH2, Q99595, Q9C1E8, Q9CQ85, Q9JKW1, Q9LN27, Q9LYG1, Q9SP35, Q9VGA2, Q9VN97, Q9VNA0, Q9Z0V7, Q9Z0V8, A0A1D8PI78, P0CR88, P0CR89, P87146, Q5M7K0, Q9NAQ9, Q6FT37, A1XJK0, A2RVP7, O48528, Q12328, Q54QM0, Q5U4U5, Q6BT35, Q6CRJ6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
41 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 20 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1176 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:48893726:T:TA | donor_gain | 1.0000 |
| X:48893896:TCA:T | donor_loss | 1.0000 |
| X:48893898:A:AC | donor_gain | 1.0000 |
| X:48893898:AC:A | donor_gain | 1.0000 |
| X:48893898:ACCAT:A | donor_loss | 1.0000 |
| X:48893899:C:CT | donor_gain | 1.0000 |
| X:48893899:CC:C | donor_gain | 1.0000 |
| X:48893899:CCA:C | donor_gain | 1.0000 |
| X:48893899:CCAT:C | donor_gain | 1.0000 |
| X:48893899:CCATT:C | donor_gain | 1.0000 |
| X:48894006:GCCAC:G | acceptor_gain | 1.0000 |
| X:48894007:CCAC:C | acceptor_gain | 1.0000 |
| X:48894007:CCACC:C | acceptor_gain | 1.0000 |
| X:48894008:CAC:C | acceptor_gain | 1.0000 |
| X:48894008:CACC:C | acceptor_gain | 1.0000 |
| X:48894009:AC:A | acceptor_gain | 1.0000 |
| X:48894010:CC:C | acceptor_gain | 1.0000 |
| X:48894011:C:CA | acceptor_loss | 1.0000 |
| X:48894011:C:CC | acceptor_gain | 1.0000 |
| X:48894012:T:A | acceptor_loss | 1.0000 |
| X:48894019:G:C | acceptor_gain | 1.0000 |
| X:48894019:G:GC | acceptor_gain | 1.0000 |
| X:48894020:T:C | acceptor_gain | 1.0000 |
| X:48894020:T:TC | acceptor_gain | 1.0000 |
| X:48894088:GTCAC:G | donor_loss | 1.0000 |
| X:48894089:TCACT:T | donor_loss | 1.0000 |
| X:48894090:CACT:C | donor_loss | 1.0000 |
| X:48894091:ACTCA:A | donor_loss | 1.0000 |
| X:48894093:TCA:T | donor_loss | 1.0000 |
| X:48894094:CA:C | donor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000005024 (X:48895294 T>A), RS1000440016 (X:48895864 G>T), RS1001415677 (X:48897616 C>G), RS1002020350 (X:48899569 C>G,T), RS1002454674 (X:48899973 G>A,T), RS1005526126 (X:48898738 C>T), RS1006576758 (X:48898296 A>G), RS1007687467 (X:48893334 A>C), RS1008642362 (X:48895537 G>A), RS1008674950 (X:48895891 G>A), RS1008707556 (X:48896374 T>C), RS1009646790 (X:48897645 C>T), RS1010686831 (X:48899993 G>T), RS1013813405 (X:48897524 C>T), RS1015118921 (X:48896572 G>A,C)
Disease associations
OMIM: gene MIM:300249 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007847_105 | Type 2 diabetes | 5.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| urushiol | decreases expression | 1 |
| chloroacetaldehyde | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| 2,3,5-(triglutathion-S-yl)hydroquinone | increases ADP-ribosylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Cidofovir | affects expression | 1 |
| Aspirin | increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Cisplatin | affects expression | 1 |
| Clodronic Acid | decreases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Ifosfamide | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
Cellosaurus cell lines
6 cell lines: 5 cancer cell line, 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B3J9 | Abcam HEK293T TIMM17B KO | Transformed cell line | Female |
| CVCL_E1LD | HyCyte HT-29 KO-hTIMM17B | Cancer cell line | Female |
| CVCL_E1LF | HyCyte Huh-7 KO-hTIMM17B | Cancer cell line | Male |
| CVCL_E2LT | HAP1 TIMM17B (-) 2 | Cancer cell line | Male |
| CVCL_E2LU | HAP1 TIMM17B (-) 3 | Cancer cell line | Male |
| CVCL_XU23 | HAP1 TIMM17B (-) 1 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.